Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$145.93
+0.04%
Mkt Cap $14.36B
Analyst Ratings
Buy
28
Hold
4
Sell
0
Price Target (89 analysts)
$203.82
Range $165.00 – $230.00
Implied Upside
+39.7%
Consensus $203.82 vs current $145.93